DATA PLANS
Download historical data for 20 million indicators using your browser.
Subscription Plans
|
Features
API GATEWAY
Direct access to our data from your apps using any programing language.
Features
|
Documentation
Already a user?
Login
Light Mode
Dark Mode
Calendar
News
Markets
Currencies
Stocks
Commodities
Bonds
Crypto
Earnings
Holidays
Indicators
Inflation Rate
Interest Rate
Unemployment Rate
GDP Growth
GDP per Capita
GDP Value
Current Account
Credit Rating
Wages Growth
Gold Reserves
Government Debt
Crude Oil Production
Gasoline Prices
Heatmap Table
More Indicators
Countries
United States
China
Japan
Canada
Australia
Brazil
Russia
India
Euro Area
United Kingdom
Germany
France
Italy
Spain
Switzerland
Singapore
More Countries
Forecasts
Countries
Indicators
Currencies
Stocks
Commodities
Bonds
Crypto
Intercept Pharmaceuticals | ICPT - Assets
Chart
Quotes
Financials
1Y
5Y
10Y
25Y
MAX
Chart
Column
Line
Area
Spline
Splinearea
Trend
Average(4)
Histogram
Variance
Mean
Maximum
Minimum
Compare
Export
API
Embed
Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.
Features
Questions?
Contact us
Already a Member?
Login
The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.
API Features
Documentation
Interested?
Click here to contact us
Please Paste this Code in your Website
width
height
Preview
Intercept Pharmaceuticals
Intercept Pharmaceuticals reported $504.08M in Assets for its fiscal quarter ending in March of 2023.
Assets
Change
Date
Acadia Pharmaceuticals
ACAD:US
USD 655.3M
67.49M
Mar/2023
Acorda Therapeutics
ACOR:US
USD 374.91M
20.69M
Mar/2023
Alnylam Pharmaceuticals
ALNY:US
USD 3.39B
154.42M
Mar/2023
Amarin
AMRN:US
USD 860.19M
25.99M
Mar/2023
Amgen
AMGN:US
USD 88.72B
23.6B
Mar/2023
Arrowhead Research
ARWR:US
USD 891.31M
181K
Mar/2023
AstraZeneca
AZN:LN
USD 96.69B
204M
Mar/2023
Biogen
BIIB:US
USD 24.6B
44.3M
Mar/2023
Bluebird Bio
BLUE:US
USD 692.74M
137.83M
Mar/2023
Eli Lilly
LLY:US
USD 53.16B
3.67B
Mar/2023
Enanta Pharmaceuticals
ENTA:US
USD 326.44M
21.09M
Mar/2023
Esperion Therapeutics
ESPR:US
USD 251.82M
3.88M
Mar/2023
Galectin Therapeutics
GALT:US
USD 20.22M
1.06M
Mar/2023
Gilead Sciences
GILD:US
USD 61.88B
1.3B
Mar/2023
GlaxoSmithKline
GSK:LN
GBP 58.6B
1.55B
Mar/2023
Incyte Corp
INCY:US
USD 5.8B
43.36M
Mar/2023
Intercept Pharmaceuticals
ICPT:US
USD 504.08M
49.63M
Mar/2023
Ionis Pharmaceuticals
IONS:US
USD 2.89B
351.34M
Mar/2023
Moderna Inc
MRNA:US
USD 24.12B
1.73B
Mar/2023
Neurocrine Biosciences
NBIX:US
USD 2.36B
8.9M
Mar/2023
Novartis
NOVN:VX
USD 112.24B
5.21B
Mar/2023
PTC Therapeutics
PTCT:US
USD 1.61B
96.78M
Mar/2023
Regeneron Pharmaceuticals
REGN:US
USD 30.06B
845.4M
Mar/2023
Sangamo BioSciences
SGMO:US
USD 440.57M
121.94M
Mar/2023
Sarepta Therapeutics
SRPT:US
USD 3.06B
68.58M
Mar/2023
Vertex Pharmaceuticals
VRTX:US
USD 18.97B
823.3M
Mar/2023
Financials
Stock Price
Assets
Cash and Equivalent
Cost of Sales
Current Assets
Current Liabilities
Debt
EBIT
EBITDA
Employees
EPS Earnings Per Share
Equity Capital and Reserves
Gross Profit on Sales
Interest Expense on Debt
Loan Capital
Market Capitalization
Net Income
Operating Expenses
Operating Profit
Ordinary Share Capital
Pre-Tax Profit
Sales Revenues
Selling and Administration Expenses
Stock
Trade Creditors
Trade Debtors